Sampling plan not risk-based during internal audit – preventing false OOS results
Assessing and Addressing Non-Risk-Based Sampling Plans during Internal Audits In pharmaceutical manufacturing, the integrity of raw material sampling plans is critical to achieving compliance and maintaining product quality. However, when…